404 related articles for article (PubMed ID: 27545110)
21. Choosing among the incretin agents and why it matters.
Unger J
J Fam Pract; 2010 May; 59(5 Suppl):S30-5. PubMed ID: 20544056
[No Abstract] [Full Text] [Related]
22. Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats.
Ávila Dde L; Araújo GR; Silva M; Miranda PH; Diniz MF; Pedrosa ML; Silva ME; de Lima WG; Costa DC
Arch Med Res; 2013 Apr; 44(3):194-202. PubMed ID: 23523961
[TBL] [Abstract][Full Text] [Related]
23. Distribution of IL-1β immunoreactive cells in pancreatic biopsies from living volunteers with new-onset type 1 diabetes: comparison with donors without diabetes and with longer duration of disease.
Reddy S; Krogvold L; Martin C; Holland R; Choi J; Woo H; Wu F; Dahl-Jørgensen K
Diabetologia; 2018 Jun; 61(6):1362-1373. PubMed ID: 29589071
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis.
Ito T; Kawabe K; Arita Y; Hisano T; Igarashi H; Funakoshi A; Sumii T; Yamanaka T; Takayanagi R
Pancreas; 2007 Mar; 34(2):254-9. PubMed ID: 17312466
[TBL] [Abstract][Full Text] [Related]
25. Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas.
Inaishi J; Saisho Y; Sato S; Kou K; Murakami R; Watanabe Y; Kitago M; Kitagawa Y; Yamada T; Itoh H
J Clin Endocrinol Metab; 2016 Jul; 101(7):2874-82. PubMed ID: 27070277
[TBL] [Abstract][Full Text] [Related]
26. Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies.
Bruggeman BS; Campbell-Thompson M; Filipp SL; Gurka MJ; Atkinson MA; Schatz DA; Jacobsen LM
Front Endocrinol (Lausanne); 2021; 12():778912. PubMed ID: 34912300
[TBL] [Abstract][Full Text] [Related]
27. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
[TBL] [Abstract][Full Text] [Related]
28. Islet cell dedifferentiation is a pathologic mechanism of long-standing progression of type 2 diabetes.
Amo-Shiinoki K; Tanabe K; Hoshii Y; Matsui H; Harano R; Fukuda T; Takeuchi T; Bouchi R; Takagi T; Hatanaka M; Takeda K; Okuya S; Nishimura W; Kudo A; Tanaka S; Tanabe M; Akashi T; Yamada T; Ogawa Y; Ikeda E; Nagano H; Tanizawa Y
JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33427207
[TBL] [Abstract][Full Text] [Related]
29. Exocrine Pancreas in Cats With Diabetes Mellitus.
Zini E; Ferro S; Lunardi F; Zanetti R; Heller RS; Coppola LM; Guscetti F; Osto M; Lutz TA; Cavicchioli L; Reusch CE
Vet Pathol; 2016 Jan; 53(1):145-52. PubMed ID: 26319779
[TBL] [Abstract][Full Text] [Related]
30. The effects of dipeptidyl-peptidase-IV inhibitor, vildagliptin, on the exocrine pancreas in spontaneously diabetic Goto-Kakizaki rats.
Mizukami H; Inaba W; Takahashi K; Kamata K; Tsuboi K; Yagihashi S
Pancreas; 2013 Jul; 42(5):786-94. PubMed ID: 23774700
[TBL] [Abstract][Full Text] [Related]
31. The ontogeny of the endocrine pancreas in the fetal/newborn baboon.
Quinn AR; Blanco CL; Perego C; Finzi G; La Rosa S; Capella C; Guardado-Mendoza R; Casiraghi F; Gastaldelli A; Johnson M; Dick EJ; Folli F
J Endocrinol; 2012 Sep; 214(3):289-99. PubMed ID: 22723715
[TBL] [Abstract][Full Text] [Related]
32. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
Drucker DJ; Nauck MA
Lancet; 2006 Nov; 368(9548):1696-705. PubMed ID: 17098089
[TBL] [Abstract][Full Text] [Related]
33. Incretin physiology and its role in type 2 diabetes mellitus.
Svec F
J Am Osteopath Assoc; 2010 Jul; 110(7 Suppl 7):eS20-4. PubMed ID: 20644202
[TBL] [Abstract][Full Text] [Related]
34. Morphometric studies in human pancreatic cancer argues against the etiological role of type 2 diabetes in pancreatic cancer.
Saruc M; Iki K; Pour PM
Histol Histopathol; 2010 Apr; 25(4):423-32. PubMed ID: 20183795
[TBL] [Abstract][Full Text] [Related]
35. Decreased pancreatic acinar cell number in type 1 diabetes.
Wright JJ; Saunders DC; Dai C; Poffenberger G; Cairns B; Serreze DV; Harlan DM; Bottino R; Brissova M; Powers AC
Diabetologia; 2020 Jul; 63(7):1418-1423. PubMed ID: 32388592
[TBL] [Abstract][Full Text] [Related]
36. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
Ishibashi K; Hara A; Fujitani Y; Uchida T; Komiya K; Tamaki M; Abe H; Ogihara T; Kanazawa A; Kawamori R; Watada H
Biochem Biophys Res Commun; 2013 Nov; 440(4):570-5. PubMed ID: 24103756
[TBL] [Abstract][Full Text] [Related]
37. Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis.
Schrader H; Menge BA; Schneider S; Belyaev O; Tannapfel A; Uhl W; Schmidt WE; Meier JJ
Gastroenterology; 2009 Feb; 136(2):513-22. PubMed ID: 19041312
[TBL] [Abstract][Full Text] [Related]
38. Feedback suppression of meal-induced glucagon-like peptide-1 (GLP-1) secretion mediated through elevations in intact GLP-1 caused by dipeptidyl peptidase-4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatment.
Baranov O; Kahle M; Deacon CF; Holst JJ; Nauck MA
Diabetes Obes Metab; 2016 Nov; 18(11):1100-1109. PubMed ID: 27300579
[TBL] [Abstract][Full Text] [Related]
39. Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits.
Spijker HS; Song H; Ellenbroek JH; Roefs MM; Engelse MA; Bos E; Koster AJ; Rabelink TJ; Hansen BC; Clark A; Carlotti F; de Koning EJ
Diabetes; 2015 Aug; 64(8):2928-38. PubMed ID: 25918235
[TBL] [Abstract][Full Text] [Related]
40. Incretin-mimetic therapies and pancreatic disease: a review of observational data.
Suarez EA; Koro CE; Christian JB; Spector AD; Araujo AB; Abraham S
Curr Med Res Opin; 2014 Dec; 30(12):2471-81. PubMed ID: 25180611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
